Botulinum neurotoxin type B — A rapid wrinkle reducer
- 1 June 2003
- journal article
- review article
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 22 (2) , 131-135
Abstract
Botulinum toxin has been used for temporary muscle paralysis for over 13 years. The off label use of neurotoxins include treatment of dynamic lines on the face and treatment of hyperhidrosis. Several forms of botulinum toxin exist, but only 2 serotypes are available commercially. Botulinum toxin B (BoTX B) is a recently US Food and Drug Administration (FDA) approved neurotoxin used for the treatment of cervical dystonia. Investigations into the use of BoTX B for skin rejuvenation have shown rapid paralysis and reduction of wrinkles. This overview highlights the current reports on the efficacy, duration, and safety of BoTX B when used for cosmetic procedures.Keywords
This publication has 9 references indexed in Scilit:
- Comparison of Botulinum Toxin Types A And B: A Bilateral and Double-Blind Randomized Evaluation in the Treatment of Canthal RhytidesDermatologic Surgery, 2003
- Autonomic Side Effects of Botulinum Toxin Type B Treatment of Cervical Dystonia and HyperhidrosisEuropean Neurology, 2002
- Botulinum Toxin Type B for Glabellar Wrinkles: A Prospective Open-Label Response StudyDermatologic Surgery, 2002
- Pain Associated With Injection of Botulinum A Exotoxin Reconstituted Using Isotonic Sodium Chloride With and Without PreservativeArchives of Dermatology, 2002
- Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosingJournal of Cosmetic and Laser Therapy, 2002
- Botulinum B treatment of the glabellar and frontalis regions: a dose response analysisJournal of Cosmetic and Laser Therapy, 2002
- Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacologySeminars in Cutaneous Medicine and Surgery, 2001
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystoniaNeurology, 1999
- Treatment of Glabellar Frown Lines with C. Botulinum‐A ExotoxinThe Journal of Dermatologic Surgery and Oncology, 1992